CADAS138 stands out as a novel therapeutic target in the realm of neurodegenerative diseases. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to alleviate disease progression. Researchers are actively exploring the precise mechanisms of CADAS138 in disease pathogenesis, paving the way for the development of nov